Overcoming Obstacles to Drug Repositioning in Japan
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2017.00729
Abstract: Drug repositioning (DR) is the process of identifying new indications for existing drugs. DR usually focuses on drugs that have cleared phase-I safety trials but has yet to show efficacy for the intended indication. Therefore,… read more here.
Keywords: phase; drug repositioning; repositioning japan; overcoming obstacles ... See more keywords